Adial says entered into amendment no. 7 to license agreement with university of virginia patent foundation

Adial pharmaceuticals inc - on december 31, entered into amendment no. 7 to license agreement with university of virginia patent foundation.adial pharmaceuticals inc - amendment no. 7 removed in its entirety diligence milestone to initiate a phase 3 clinical trial by december 31, 2019.adial pharmaceuticals - co to pay upon execution of amendment no. 7, payment of $20,000 that had been due upon initiation of a phase 3 clinical trial.adial pharmaceuticals - expects to dose a first patient with a licensed product in a phase 3 clinical trial on or before march 31, 2020.
ADIL Ratings Summary
ADIL Quant Ranking